Sigh Ventilation in Patients With Trauma: The SiVent Randomized Clinical Trial.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
28 11 2023
Historique:
pmc-release: 25 04 2024
medline: 29 11 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

Among patients receiving mechanical ventilation, tidal volumes with each breath are often constant or similar. This may lead to ventilator-induced lung injury by altering or depleting surfactant. The role of sigh breaths in reducing ventilator-induced lung injury among trauma patients at risk of poor outcomes is unknown. To determine whether adding sigh breaths improves clinical outcomes. A pragmatic, randomized trial of sigh breaths plus usual care conducted from 2016 to 2022 with 28-day follow-up in 15 academic trauma centers in the US. Inclusion criteria were age older than 18 years, mechanical ventilation because of trauma for less than 24 hours, 1 or more of 5 risk factors for developing acute respiratory distress syndrome, expected duration of ventilation longer than 24 hours, and predicted survival longer than 48 hours. Sigh volumes producing plateau pressures of 35 cm H2O (or 40 cm H2O for inpatients with body mass indexes >35) delivered once every 6 minutes. Usual care was defined as the patient's physician(s) treating the patient as they wished. The primary outcome was ventilator-free days. Prespecified secondary outcomes included all-cause 28-day mortality. Of 5753 patients screened, 524 were enrolled (mean [SD] age, 43.9 [19.2] years; 394 [75.2%] were male). The median ventilator-free days was 18.4 (IQR, 7.0-25.2) in patients randomized to sighs and 16.1 (IQR, 1.1-24.4) in those receiving usual care alone (P = .08). The unadjusted mean difference in ventilator-free days between groups was 1.9 days (95% CI, 0.1 to 3.6) and the prespecified adjusted mean difference was 1.4 days (95% CI, -0.2 to 3.0). For the prespecified secondary outcome, patients randomized to sighs had 28-day mortality of 11.6% (30/259) vs 17.6% (46/261) in those receiving usual care (P = .05). No differences were observed in nonfatal adverse events comparing patients with sighs (80/259 [30.9%]) vs those without (80/261 [30.7%]). In a pragmatic, randomized trial among trauma patients receiving mechanical ventilation with risk factors for developing acute respiratory distress syndrome, the addition of sigh breaths did not significantly increase ventilator-free days. Prespecified secondary outcome data suggest that sighs are well-tolerated and may improve clinical outcomes. ClinicalTrials.gov Identifier: NCT02582957.

Identifiants

pubmed: 37877609
pii: 2811211
doi: 10.1001/jama.2023.21739
pmc: PMC10600720
doi:

Banques de données

ClinicalTrials.gov
['NCT02582957']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1982-1990

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Richard K Albert (RK)

Department of Medicine, University of Colorado, Aurora.

Gregory J Jurkovich (GJ)

Department of Surgery, University of California, Davis.

John Connett (J)

Division of Biostatistics, University of Minnesota, Minneapolis.

Erika S Helgeson (ES)

Division of Biostatistics, University of Minnesota, Minneapolis.

Angela Keniston (A)

Department of Medicine, University of Colorado, Aurora.

Helen Voelker (H)

Division of Biostatistics, University of Minnesota, Minneapolis.

Sarah Lindberg (S)

Division of Biostatistics, University of Minnesota, Minneapolis.

Jennifer L Proper (JL)

Division of Biostatistics, University of Minnesota, Minneapolis.

Grant Bochicchio (G)

Department of Surgery, Washington University, St Louis, St Louis, Missouri.

Deborah M Stein (DM)

Department of Surgery, University of Maryland, Baltimore.

Christian Cain (C)

Department of Surgery, University of Maryland, Baltimore.

Ron Tesoriero (R)

Department of Surgery, University of Maryland, Baltimore.

Carlos V R Brown (CVR)

Department of Surgery, University of Texas, Austin.

James Davis (J)

Department of Surgery, University of California San Francisco, Fresno.

Lena Napolitano (L)

Department of Surgery, University of Michigan, Ann Arbor.

Thomas Carver (T)

Department of Surgery, Medical College of Wisconsin, Milwaukee.

Mark Cipolle (M)

Department of Surgery, Lehigh Valley Health Network, Bethlehem, Pennsylvania.

Luis Cardenas (L)

Department of Surgery, Christiana Care Health System, Wilmington, Delaware.

Joseph Minei (J)

Department of Surgery, University of Texas Southwestern, Dallas.

Raminder Nirula (R)

Department of Surgery, University of Utah, Salt Lake City.

Jay Doucet (J)

Department of Surgery, University of California San Diego.

Preston R Miller (PR)

Department of Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Jeffrey Johnson (J)

Department of Surgery, Henry Ford Hospital, Detroit, Michigan.

Kenji Inaba (K)

Department of Surgery, University of Southern California Los Angeles County.

Lillian Kao (L)

Department of Surgery, University of Texas, Houston.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH